Dr. Makram Mehany, founder of the Global NAPI group, spent his life and career, serving the Egyptian pharmaceutical industry by paving the way towards a more affordable and diverse market by becoming a leader in the production, distribution and promotion of the highest quality therapeutic options in healthcare.

In the mid-1980’s, the Egyptian healthcare system was receiving national focus on both the public and private sector level. This was reflected by a rise in the number of hospitals and healthcare centers constructed, and through the marked improvement in the quality of healthcare services being introduced to the public. It was during this time that Makram Mehany took the first step towards changing the future of Egyptian Healthcare. In 1987 he founded his first scientific office, Makram Mehany Pharmaceuticals (MMP) for sales and marketing activities, representing a number of multinational companies. This was a challenging time for the Egyptian pharmaceutical market. During this difficult era, the market was suffering from critical shortages of many imported medicines, with no available alternatives. The goal of the scientific office was to maintain the stability of the Egyptian market and minimize the negative impact created from the shortages of vital therapy solutions.

In 1995, Makram Mehany established the “Global Pharmaceutical Company”. In less than a year, that would later became “Global Napi Pharmaceuticals”, after the acquisition of the “North African Pharmaceutical Industries” production premises. The factory went through a rigorous make over to allow for compliance with the Highest Good Manufacturing Practice (GMP) standards and multinational authority’s recognition. The production site was inaugurated in February 1998 by the Egyptian & Algerian Ministers of Health and GNP started production in February 1998 with its first product “Clomid” under license from Sanofi-Aventis.

Global Napi today enjoys a presence of over 45 years of in the pharmaceutical industry. Three giant pharmaceutical production sites, as well as one of the largest scientific offices in the region, with 4 branches across Egypt, all currently reside under the umbrella of the “Global Pharmaceutical Group”, producing and marketing a wide range of pharmaceutical products both nationally and internationally. Dr. Makram Mehany, quotes: